D. E. Shaw & Co., Inc. Covetrus, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$20.69 - $20.91 $4.94 Million - $4.99 Million	-238,534 Reduced 78.96%	63,547 $1.33 Million
Q2 2022 Aug 15, 2022	SELL	$13.8 - $20.82 $11.4 Million - $17.2 Million	-827,853 Reduced 73.27%	302,081 $6.27 Million
Q1 2022 May 16, 2022	BUY	$15.96 - $18.87 $1.62 Million - $1.91 Million	101,199 Added 9.84%	1,129,934 $19 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $20.37 $8.04 Million - $9.76 Million	479,008 Added 87.14%	1,028,735 $20.5 Million
Q3 2021 Nov 15, 2021	BUY	$18.14 - $27.03 $9.38 Million - $14 Million	516,968 Added 1578.09%	549,727 $9.97 Million
Q2 2021 Aug 16, 2021	BUY	$25.24 - $30.86 $527,945 - $645,498	20,917 Added 176.63%	32,759 $884,000
Q1 2021 May 17, 2021	SELL	$28.29 - $39.89 $1.61 Million - $2.26 Million	-56,735 Reduced 82.73%	11,842 $355,000
Q4 2020 Feb 16, 2021	BUY	$24.45 - $31.59 $470,026 - $607,286	19,224 Added 38.95%	68,577 $1.97 Million
Q3 2020 Nov 16, 2020	BUY	$17.22 - $24.59 $123,760 - $176,728	7,187 Added 17.04%	49,353 $1.2 Million
Q2 2020 Aug 14, 2020	BUY	$6.46 - $19.27 $75,381 - $224,861	11,669 Added 38.26%	42,166 $754,000
Q1 2020 May 15, 2020	BUY	$5.64 - $15.23 $15,205 - $41,060	2,696 Added 9.7%	30,497 $248,000
Q4 2019 Feb 14, 2020	SELL	$8.8 - $14.93 $194,647 - $330,236	-22,119 Reduced 44.31%	27,801 $367,000
Q3 2019 Nov 14, 2019	SELL	$11.76 - $25.57 $354,164 - $770,066	-30,116 Reduced 37.63%	49,920 $594,000
Q2 2019 Aug 14, 2019	SELL	$22.88 - $33.27 $590,784 - $859,064	-25,821 Reduced 24.39%	80,036 $1.96 Million
Q1 2019 May 15, 2019	BUY	$31.52 - $46.19 $3.34 Million - $4.89 Million	105,857 New	105,857 $3.37 Million

Others Institutions Holding CVET

# of Institutions

Shares Held

72.9K

Call Options Held

Put Options Held

View Full List

About COVETRUS, INC.

Ticker CVET
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 140,123,008
Description
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...

More about CVET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account